- Focus is on role of LRRK2 in PD-related inflammatory processes
- Does LRRK2 inhibition in the periphery block α-syn driven pro-inflammation and neurodegeneration?
- Do macrophages from LRRK2 mutation carriers and early PD patients demonstrate enhanced pro-inflammatory responses to α-syn?
- What is the role of LRRK2 activity in these responses?